<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2016="http://publications.europa.eu/resource/schema/ted/2016/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S03.E01" DOC_ID="424002-2019" EDITION="2019174"><TECHNICAL_SECTION><RECEPTION_ID>19-435935-001</RECEPTION_ID><DELETION_DATE>20191218</DELETION_DATE><FORM_LG_LIST>ES </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>174</NO_OJ><DATE_PUB>20190910</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2019/S 174-424002</NO_DOC_OJS><URI_LIST><URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:424002-2019:TEXT:ES:HTML</URI_DOC></URI_LIST><LG_ORIG>ES</LG_ORIG><ISO_COUNTRY VALUE="ES"/><IA_URL_GENERAL>https://contrataciondelestado.es</IA_URL_GENERAL><ORIGINAL_CPV CODE="33652000">Antineoplastic and immunomodulating agents</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="ES414">Palencia</n2016:PERFORMANCE_NUTS><n2016:CA_CE_NUTS CODE="ES414">Palencia</n2016:CA_CE_NUTS><n2016:TENDERER_NUTS CODE="ES300">Madrid</n2016:TENDERER_NUTS><VALUES><VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">799200.03</VALUE></VALUES></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20190909</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="3">Regional or local authority</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01B03</HEADING><INITIATOR>01</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иcпaния</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Антинеопластични средства и имуномодулатори</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Španělsko</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastika a imunomodulátory</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Spanien</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastiske og immunmodulerende midler</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Spanien</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastische und immunmodulierende Mittel</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισπανία</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Spain</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastic and immunomodulating agents</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>España</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Agentes antineoplásicos e inmunomoduladores</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Hispaania</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastilised ja immuunmoduleerivad ained</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Espanja</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Solunsalpaajat ja sytostaatit sekä immunomodulantit</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Espagne</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antinéoplasiques et immunomodulateurs</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Spáinn, an</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastic and immunomodulating agents</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Španjolska</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastični lijekovi i imunomodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Spanyolország</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Daganatellenes és immunmodulátor szerek</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Spagna</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Agenti antineoplastici e immunomodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Ispanija</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antinavikiniai vaistai ir imunomoduliatoriai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Spānija</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastiskie līdzekļi un imūnmodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Spanja</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Aġenti ta' l-antineoplastika u ta' l-immunomodulaturi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Spanje</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastische en immunomodulerende middelen</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Hiszpania</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Środki przeciwnowotworowe i immunomodulacyjne</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Espanha</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplásicos e imunomoduladores</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Spania</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplazice şi imunomodulatoare</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Španielsko</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Antineoplastické a imunomodulačné činidlá</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Španija</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Zdravila z delovanjem na novotvorbe in imunomodulatorji</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Spanien</TI_CY><TI_TOWN>Palencia</TI_TOWN><TI_TEXT><P>Cytostatika/cytotoxiska medel och immunmodulerande medel</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="ES">Gerencia de Asistencia Sanitaria de Palencia</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="ES"><LEGAL_BASIS VALUE="32014L0024"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Gerencia de Asistencia Sanitaria de Palencia</OFFICIALNAME><NATIONALID>Q3469002D</NATIONALID><ADDRESS>Avenida Donantes de Sangre, s/n</ADDRESS><TOWN>Palencia</TOWN><POSTAL_CODE>34005</POSTAL_CODE><COUNTRY VALUE="ES"/><CONTACT_POINT>Gerencia de Asistencia Sanitaria de Palencia</CONTACT_POINT><PHONE>+34 979167053</PHONE><E_MAIL>contratacion.hrcr@saludcastillayleon.es</E_MAIL><n2016:NUTS CODE="ES414"/><URL_GENERAL>https://contrataciondelestado.es</URL_GENERAL><URL_BUYER>https://contrataciondelestado.es/wps/poc?uri=deeplink:perfilContratante&amp;idBp=K7iCRRS2m1AQK2TEfXGy%2BA%3D%3D</URL_BUYER></ADDRESS_CONTRACTING_BODY><CA_TYPE VALUE="REGIONAL_AUTHORITY"/><CA_ACTIVITY VALUE="HEALTH"/></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Suministro del medicamento Olaparib (Lynparza 50 mg. cápsulas) para el Complejo Asistencial Universitario de Palencia</P></TITLE><REFERENCE_NUMBER>2020008604</REFERENCE_NUMBER><CPV_MAIN><CPV_CODE CODE="33652000"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SUPPLIES"/><SHORT_DESCR><P>Suministro del medicamento Olaparib (Lynparza 50 mg. cápsulas) para el Complejo Asistencial Universitario de Palencia.</P></SHORT_DESCR><VAL_TOTAL CURRENCY="EUR">799200.03</VAL_TOTAL><NO_LOT_DIVISION/><OBJECT_DESCR ITEM="1"><n2016:NUTS CODE="ES414"/><MAIN_SITE><P>Lugar: Farmacia del Hospital Rio Carrión del Complejo Asistencial Universitario de Palencia. Avenida Donantes de Sangre, s/n, 34005 Palencia.</P></MAIN_SITE><SHORT_DESCR><P>Suministro del medicamento Olaparib (Lynparza 50 mg. cápsulas) para el Complejo Asistencial Universitario de Palencia.</P></SHORT_DESCR><AC><AC_PRICE/></AC><OPTIONS/><OPTIONS_DESCR><P>Obligatoria para el empresario.</P></OPTIONS_DESCR><NO_EU_PROGR_RELATED/></OBJECT_DESCR></OBJECT_CONTRACT><PROCEDURE><PT_AWARD_CONTRACT_WITHOUT_CALL><D_ACCORDANCE_ARTICLE><D_PROTECT_RIGHTS/></D_ACCORDANCE_ARTICLE><D_JUSTIFICATION><P>Se trata de un procedimiento negociado sin publicidad por exclusividad.</P></D_JUSTIFICATION></PT_AWARD_CONTRACT_WITHOUT_CALL><NO_CONTRACT_COVERED_GPA/></PROCEDURE><AWARD_CONTRACT ITEM="1"><CONTRACT_NO>2020008604</CONTRACT_NO><TITLE><P>Suministro del medicamento Olaparib (Lynparza 50 mg. cápsulas) para el Complejo Asistencial Universitario de Palencia</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2019-09-03</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_SME>0</NB_TENDERS_RECEIVED_SME><NB_TENDERS_RECEIVED_OTHER_EU>0</NB_TENDERS_RECEIVED_OTHER_EU><NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Astrazeneca Farmacéutica Spain, S. A.</OFFICIALNAME><NATIONALID>A36002129</NATIONALID><ADDRESS>C/ Serrano Galvache, 56, parque norte, edificio Álamo</ADDRESS><TOWN>Madrid</TOWN><POSTAL_CODE>28033</POSTAL_CODE><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES300"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_ESTIMATED_TOTAL CURRENCY="EUR">799200.04</VAL_ESTIMATED_TOTAL><VAL_TOTAL CURRENCY="EUR">799200.03</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><COMPLEMENTARY_INFO><ADDRESS_REVIEW_BODY><OFFICIALNAME>Tribunal Administrativo de Recursos Contractuales de Castilla y León</OFFICIALNAME><ADDRESS>Plaza de la Catedral, 5</ADDRESS><TOWN>Zamora</TOWN><POSTAL_CODE>49001</POSTAL_CODE><COUNTRY VALUE="ES"/><E_MAIL>tribunalcontratoscyl@cccyl.es</E_MAIL></ADDRESS_REVIEW_BODY><DATE_DISPATCH_NOTICE>2019-09-09</DATE_DISPATCH_NOTICE></COMPLEMENTARY_INFO></F03_2014></FORM_SECTION></TED_EXPORT>